EP Patent

EP3909966B1 — 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid for use in therapy

Assigned to Sage Therapeutics Inc · Expires 2025-07-09 · 1y expired

What this patent protects

Patent listed against Zurzuvae.

Drugs covered by this patent

Patent Metadata

Patent number
EP3909966B1
Jurisdiction
EP
Classification
—
Expires
2025-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.